Skip to main content
EJNMMI Research

Table 1 Imaging/biodistribution data collection schedule

From: Feasibility and advantage of adding 131I-MIBG to 90Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors

 

Day 0

Day 1

Day 2

Radiopharmaceutical injection (131I-MIBG and 111In-pentetreotide)

X

  

Blood samples

X (1 and 4 h)

X

X

Whole-body conjugate views

X

X

X

SPECT

X

X

X

Back to article page